drugset / Trial / NCT06366698

Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia

NCT06366698

Phase 3 Unknown 900 enrolled Arrowhead Regional Medical Center
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to assess whether administering intravenous iron early in pregnancy, compared to standard oral iron treatment, can enhance hemoglobin levels before delivery and reduce the need for blood transfusions in patients with iron deficiency anemia. Patients diagnosed with iron deficiency anemia were randomly assigned to receive either oral or intravenous iron. Before treatment initiation, patients completed a symptom questionnaire baseline hemoglobin, and ferritin levels were measured. Follow-up visits occurred four weeks later and at 24 to 28 weeks gestation, involving reassessment of symptoms, laboratory testing, and monitoring of treatment adherence. Final hemoglobin levels were determined before delivery, and data on the need for blood transfusion at delivery were recorded.

Timeline

Start
2023-11-21
Primary completion
2025-12-30
Completion
2025-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 325 mg Oral
Comparator Iron sucrose Unknown 200 mg Intravenous